Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT01364064 · COMPLETED
Trial details
- NCT number
- NCT01364064
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-06-01
- Enrollment
- 1153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.